Clinical and pathological phenotypes of LRP10 variant carriers with dementia
Manuscript Number:
20-0318R1
Author(s):
Vincenzo Bonifati, Guido Breedveld, Hanneke Geut, Demy J.S. Kuipers, Marialuisa Quadri, Annemieke J. Rozemuller, Leonie J.M. Vergouw, Frank Jan de Jong, John C. van Swieten, Wilma D.J. van de Berg
Disclosures
Vincenzo Bonifati
Nothing to Disclose
Guido Breedveld
Nothing to Disclose
Frank Jan de Jong
Nothing to Disclose
Hanneke Geut
Nothing to Disclose
Demy J.S. Kuipers
Nothing to Disclose
Marialuisa Quadri
Nothing to Disclose
Annemieke J. Rozemuller
Nothing to Disclose
Wilma D.J. van de Berg
Consulting Fees:
Consulting fees from Lysosomal Therapeutics
Lecture Fees:
Lecture fee from Roche Pharma Research and Early Development, F. Hoffmann-La Roche Ltd.
Grants
Agency:
Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche
Dates:
2014, 2019
Agency:
Lysosomal Therapeutics Inc., Cambridge USA
Dates:
2018
Agency:
Crossbeta Sciences, The Netherlands
Dates:
2019
Agency:
Lundbeck, Denmark
Dates:
2019
John C. van Swieten
Consulting Fees:
Lundbeck, one-day meeting about potential tau trial visit in december 2019